| Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 | Critical Care Medicine | 2013 | 4.9K |
| Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Intensive Care Medicine | 2013 | 3K |
| Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts | Circulation | 2013 | 359 |
| A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic | Genome Research | 2013 | 325 |
| Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial | Clinical Infectious Diseases | 2013 | 250 |
| Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials | BMJ, The | 2013 | 226 |
| Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy | British Journal of Haematology | 2013 | 180 |
| Anaphylaxis: clinical patterns, mediator release, and severity | Journal of Allergy and Clinical Immunology | 2013 | 173 |
| Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) | Journal of the American College of Cardiology | 2013 | 159 |
| Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia | Antimicrobial Agents and Chemotherapy | 2013 | 148 |
| Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial | Journal of the American Heart Association | 2013 | 145 |
| Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy | American Journal of Human Genetics | 2013 | 142 |
| Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients | Circulation | 2013 | 135 |
| Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis | Neuromuscular Disorders | 2013 | 126 |
| Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease | Rheumatology | 2013 | 122 |
| Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells | Journal of Experimental Medicine | 2013 | 121 |
| Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy | American Journal of Human Genetics | 2013 | 120 |
| Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib | Molecular Cancer Therapeutics | 2013 | 117 |
| Cranioplasty with custom-made titanium plates--14 years experience | Neurosurgery | 2013 | 116 |
| Clinical review: early patient mobilization in the ICU | Critical Care | 2013 | 112 |
| Genomic insights to control the emergence of vancomycin-resistant enterococci | MBio | 2013 | 112 |
| Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial | Pain | 2013 | 109 |
| Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis | Stroke | 2013 | 106 |
| Early goal-directed sedation versus standard sedation in mechanically ventilated critically ill patients: a pilot study* | Critical Care Medicine | 2013 | 98 |
| New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? | Cardiovascular Drugs and Therapy | 2013 | 94 |
